These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 34505628)

  • 1. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
    Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of PSMD7 as a prognostic factor correlated with immune infiltration in head and neck squamous cell carcinoma.
    Zhang S; Yu S; Wang J; Cheng Z
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33687056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBE2C promotes the progression of head and neck squamous cell carcinoma.
    Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
    Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of BASP1 Indicates a Poor Prognosis in Head and Neck Squamous Cell Carcinoma.
    Jaikumarr Ram A; Girija As S; Jayaseelan VP; Arumugam P
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3435-3439. PubMed ID: 33247706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
    Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
    Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.
    Li J; Yan T; Wu X; Ke X; Li X; Zhu Y; Yang J; Li Z
    BMC Cancer; 2021 Nov; 21(1):1205. PubMed ID: 34772357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance and biological functions of chemokine CXCL3 in head and neck squamous cell carcinoma.
    Guan J; Weng J; Ren Q; Zhang C; Hu L; Deng W; Lu S; Dong X; Li W; Li Y; Wang W
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34870709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma.
    Xu W; Zou H; Wei Z; Song C; Tang C; Yin X; Wang Y; Han S; Cai Y; Han W
    Aging (Albany NY); 2019 Jun; 11(11):3601-3623. PubMed ID: 31170090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
    Li B; Zhu J; Meng L
    Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
    Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
    Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas.
    Kolenda T; Guglas K; Kopczyńska M; Teresiak A; Bliźniak R; Mackiewicz A; Lamperska K; Mackiewicz J
    Cells; 2019 Apr; 8(4):. PubMed ID: 31010087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity protein 1/microRNA-92b forms a feedback loop promoting the migration and invasion of head and neck squamous cell carcinoma.
    Pang P; Fang H; Wu H; Wang S; Liu M; Jin S; Qi Z; Li Z; Liu F; Sun C
    Bioengineered; 2021 Dec; 12(2):11397-11409. PubMed ID: 34905435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis.
    Liu Z; Liu H; Dong Q; Li H; Zhang B; Liu Y; Zhong L; Tang H
    BMC Cancer; 2021 Aug; 21(1):951. PubMed ID: 34433433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma.
    Feng X; Zheng Z; Wang Y; Song G; Wang L; Zhang Z; Zhao J; Wang Q; Lun L
    Exp Biol Med (Maywood); 2021 Mar; 246(5):538-546. PubMed ID: 33241710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin.
    Ji Y; Feng G; Hou Y; Yu Y; Wang R; Yuan H
    Cancer Med; 2020 Jun; 9(11):3954-3963. PubMed ID: 32277605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP39 Promotes the Viability and Migration of Head and Neck Squamous Cell Carcinoma Cell by Regulating STAT1.
    Hu Y; Wang Y; Hu W; Hu C; Wang B; Liu C; Deng A; Shen B; Wu K; Liu Y
    Technol Cancer Res Treat; 2024; 23():15330338241250298. PubMed ID: 38706215
    [No Abstract]   [Full Text] [Related]  

  • 19. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
    Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast activation protein (FAP) as a prognostic biomarker in multiple tumors and its therapeutic potential in head and neck squamous cell carcinoma.
    Li R; Nan X; Li M; Rahhal O
    Oncol Res; 2024; 32(8):1323-1334. PubMed ID: 39055892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.